Driving gene-engineered T cell immunotherapy of cancer http://www.nature.com/cr/journal/vaop/ncurrent/full/cr2016154a.html；Dendritic cell-based immunotherapy http://www.nature.com/cr/journal/vaop/ncurrent/abs/cr2016157a.html；Immune targets and neoantigens for cancer immunotherapy and precision medicine http://www.nature.com/cr/journal/vaop/ncurrent/abs/cr2016155a.html